ReviewFrontiers in immunology2020

Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment.

Yuxiao Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.